Gastroenterology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the global gastroenterology market. The report provides an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges, while offering valuable insights into the overall market structure. This research publication presents exclusive data and statistical projections outlining the anticipated growth trajectory of the gastroenterology market from 2025 to 2032.

The global gastroenterology market size is projected to rise from US$ 38.46 Bn in 2025 to US$ 56.54 Bn by 2032, registering a CAGR of 5.7% during the forecast period. Market growth is primarily driven by the increasing prevalence of gastrointestinal disorders across both aging and younger populations, along with rising awareness of advanced diagnostic and therapeutic technologies.

Key Insights:

Gastroenterology Market Size (2025E): US$ 38.46 Billion
Projected Market Value (2032F): US$ 56.54 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 5.7%

Gastroenterology Market - Report Scope:

Gastroenterology focuses on the diagnosis, treatment, and management of disorders affecting the digestive system, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder. The market encompasses branded and generic pharmaceutical therapies, biologics, and supportive treatment solutions used in managing chronic and acute gastrointestinal conditions.

Rising incidences of lifestyle-related digestive disorders-caused by sedentary habits, poor dietary patterns, and increased consumption of processed and fast foods containing preservatives and artificial ingredients-have significantly contributed to market expansion. Conditions such as gallstones, ulcerative colitis, Crohn's disease, and Irritable Bowel Syndrome (IBS) are becoming increasingly prevalent worldwide, creating sustained demand for effective gastroenterology treatments.

Market Growth Drivers:

The global gastroenterology market is driven by the growing burden of gastrointestinal diseases among both elderly and younger populations. Increasing awareness regarding early diagnosis and treatment, supported by improved access to healthcare services, is accelerating market growth. Technological advancements in drug development, biologics, and targeted therapies have enhanced treatment efficacy and patient outcomes.

Additionally, changing dietary habits, urbanization, and stressful professional lifestyles have led to a surge in digestive health issues globally. The rising adoption of advanced diagnostic tools and increased investments in gastrointestinal research and development further contribute to market expansion.

Market Restraints:

Despite steady growth, the gastroenterology market faces challenges such as high treatment costs associated with biologics and branded drugs. Limited access to advanced therapies in low- and middle-income regions restricts market penetration. Adverse effects related to long-term gastrointestinal drug usage and stringent regulatory requirements for drug approvals also pose challenges for market players.

Market Opportunities:

The gastroenterology market presents significant growth opportunities through the development of novel biologics, biosimilars, and personalized medicine approaches. Expansion in emerging economies with improving healthcare infrastructure and rising awareness of digestive health offers strong growth potential. Increased focus on preventive healthcare, early screening programs, and digital health integration in gastroenterology practices is expected to create new revenue opportunities.

Strategic collaborations between pharmaceutical companies, research institutions, and healthcare providers are anticipated to accelerate innovation and expand treatment accessibility worldwide.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the global gastroenterology market?
Which disease indications and drug types are expected to witness the highest demand?
How are lifestyle changes influencing the prevalence of gastrointestinal disorders?
Who are the leading players in the gastroenterology market, and what strategies are they adopting?
What are the emerging trends and future growth prospects across regional markets?

Competitive Intelligence and Business Strategy:

Leading companies in the global gastroenterology market focus on product innovation, portfolio expansion, and strategic partnerships to strengthen their market position. Key players invest heavily in R&D to develop advanced therapies, including biologics and targeted treatments, for chronic gastrointestinal conditions. Emphasis on expanding generic drug offerings, improving patient compliance, and entering emerging markets remains central to competitive strategies.

Key Companies Profiled:

AbbVie Inc.
Allergan plc
AstraZeneca plc
Boehringer Ingelheim International GmbH
Eisai Co., Ltd.
GlaxoSmithKline plc
Johnson & Johnson
Novartis International AG
Pfizer Inc.
Procter & Gamble Co.
Takeda Pharmaceutical Company Limited

Gastroenterology Market Research Segmentation:

By Type

Branded
Generics

By Application

Crohn's Disease
Ulcerative Colitis
Irritable Bowel Disease (IBD)
Others

By End-user

Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

Product Code: PMRREP35347

1. Executive Summary

1.1. Gastroenterology Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Pipeline Analysis
3.3. Product Adoption Analysis
3.4. Value Chain Analysis
3.5. Key Promotional Strategies by Manufacturers
3.6. PESTLE Analysis
3.7. Porter's Five Force Analysis

4. Gastroenterology Market Outlook:

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Gastroenterology Market Outlook: Form
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Type, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
  - 4.3.3.1. Branded
  - 4.3.3.2. Generics
- 4.3.4. Market Attractiveness Analysis: Type
4.4. Global Gastroenterology Market Outlook: Application
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
  - 4.4.3.1. Crohn's Disease
  - 4.4.3.2. Ulcerative Colitis
  - 4.4.3.3. Irritable Bowel Syndrome (IBD)
  - 4.4.3.4. Others
- 4.4.4. Market Attractiveness Analysis: Application
4.5. Global Gastroenterology Market Outlook: End-user
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
  - 4.5.3.1. Retail Pharmacies
  - 4.5.3.2. Hospital Pharmacies
  - 4.5.3.3. Online Pharmacies
- 4.5.4. Market Attractiveness Analysis: End-user

5. Global Gastroenterology Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Gastroenterology Market Outlook:

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By End-user
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 6.4.1. Branded
- 6.4.2. Generics
6.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 6.5.1. Crohn's Disease
- 6.5.2. Ulcerative Colitis
- 6.5.3. Irritable Bowel Syndrome (IBD)
- 6.5.4. Others
6.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 6.6.1. Retail Pharmacies
- 6.6.2. Hospital Pharmacies
- 6.6.3. Online Pharmacies
6.7. Market Attractiveness Analysis

7. Europe Gastroenterology Market Outlook:

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Type
- 7.2.3. By Application
- 7.2.4. By End-user
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 7.4.1. Branded
- 7.4.2. Generics
7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.5.1. Crohn's Disease
- 7.5.2. Ulcerative Colitis
- 7.5.3. Irritable Bowel Syndrome (IBD)
- 7.5.4. Others
7.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 7.6.1. Retail Pharmacies
- 7.6.2. Hospital Pharmacies
- 7.6.3. Online Pharmacies
7.7. Market Attractiveness Analysis

8. East Asia Gastroenterology Market Outlook:

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Type
- 8.2.3. By Application
- 8.2.4. By End-user
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 8.4.1. Branded
- 8.4.2. Generics
8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.5.1. Crohn's Disease
- 8.5.2. Ulcerative Colitis
- 8.5.3. Irritable Bowel Syndrome (IBD)
- 8.5.4. Others
8.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 8.6.1. Retail Pharmacies
- 8.6.2. Hospital Pharmacies
- 8.6.3. Online Pharmacies
8.7. Market Attractiveness Analysis

9. South Asia & Oceania Gastroenterology Market Outlook:

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Type
- 9.2.3. By Application
- 9.2.4. By End-user
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 9.4.1. Branded
- 9.4.2. Generics
9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.5.1. Crohn's Disease
- 9.5.2. Ulcerative Colitis
- 9.5.3. Irritable Bowel Syndrome (IBD)
- 9.5.4. Others
9.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 9.6.1. Retail Pharmacies
- 9.6.2. Hospital Pharmacies
- 9.6.3. Online Pharmacies
9.7. Market Attractiveness Analysis

10. Latin America Gastroenterology Market Outlook:

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Type
- 10.2.3. By Application
- 10.2.4. By End-user
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) Analysis and Forecast, By Type, 2025-2032
- 10.4.1. Branded
- 10.4.2. Generics
10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.5.1. Crohn's Disease
- 10.5.2. Ulcerative Colitis
- 10.5.3. Irritable Bowel Syndrome (IBD)
- 10.5.4. Others
10.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 10.6.1. Retail Pharmacies
- 10.6.2. Hospital Pharmacies
- 10.6.3. Online Pharmacies
10.7. Market Attractiveness Analysis

11. Middle East & Africa Gastroenterology Market Outlook:

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Type
- 11.2.3. By Application
- 11.2.4. By End-use
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) Analysis and Forecast, By Form, 2025-2032
- 11.4.1. Branded
- 11.4.2. Generics
11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.5.1. Crohn's Disease
- 11.5.2. Ulcerative Colitis
- 11.5.3. Irritable Bowel Syndrome (IBD)
- 11.5.4. Others
11.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
- 11.6.1. Retail Pharmacies
- 11.6.2. Hospital Pharmacies
- 11.6.3. Online Pharmacies
11.7. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2025
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. AbbVie Inc
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. Allergan plc
- 12.3.3. AstraZeneca plc
- 12.3.4. Boehringer Ingelheim International GmbH
- 12.3.5. Eisai Co., Ltd.
- 12.3.6. GlaxoSmithKline plc
- 12.3.7. Johnson & Johnson
- 12.3.8. Novartis International AG
- 12.3.9. Pfizer Inc.
- 12.3.10. Procter & Gamble Co.
- 12.3.11. Takeda Pharmaceutical Company Limited

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations